Private Label Peptide Anti-Aging Night Cream Manufacturer

The minimum order quantity for private label peptide anti-aging night cream depends heavily on whether you are working with a stock (white-label) formula or commissioning a fully custom formulation. For stock formulas — where the manufacturer already has a finished, stability-tested base — MOQs typically fall between 100 and 300 units. Some overseas manufacturers, particularly in South Korea and China, will go as low as 50 units for stock SKUs, though at that scale the per-unit economics are rarely favorable once you factor in airfreight and customs duties. For custom formulations — where a cosmetic chemist develops a new formula to your brief — the MOQ typically rises to 500–2,000 units. The reason is straightforward: the manufacturer needs to amortize the cost of formula development, stability testing, raw material sourcing (peptide actives often require a minimum raw material purchase), and equipment setup across a sufficient number of units to be commercially viable. Several factors push MOQs up or down. Unusual peptide actives — for example, biomimetic copper peptides or GHK-Cu at meaningful concentrations — often have a minimum raw material order from the ingredient supplier themselves, which can force the contract manufacturer to set a higher unit MOQ. Conversely, if you are willing to use the manufacturer's house packaging (a generic airless pump or standard glass jar from their existing supplier) rather than custom-decorated or bespoke packaging, many manufacturers will reduce MOQ by 20–40% because they eliminate the separate packaging tooling minimum. Geography also matters. US-based and EU-based manufacturers tend to have higher MOQs (300–1,000 units for custom) because their labor and overhead costs are higher, but they offer faster domestic shipping, easier regulatory alignment, and simpler audits. Asian contract manufacturers often accept lower unit MOQs but require longer lead times and carry more regulatory translation burden if your target market is the US or EU. The most common mistake founders make is treating MOQ as a fixed number. In reality it is a negotiation, and your strongest lever is committing to a follow-on purchase order at a higher quantity in the contract — many manufacturers will halve their stated MOQ if you guarantee a second run within 6 months. The AJ Cosmo Labs app lets you post your target MOQ directly in your brief so only manufacturers who can meet your threshold respond, saving you from this negotiation with partners who simply cannot serve small runs.

Private label peptide anti-aging night cream costs between $4 and $18 per unit at the manufacturing level, before packaging, labeling, and landed freight are added. The range is wide because peptide actives themselves span an enormous cost spectrum — a formula built on Matrixyl 3000 at 5% will cost meaningfully less than one centered on palmitoyl tripeptide-38 (Matrixyl Morphomics) or a proprietary peptide complex licensed from Lipotec or Lucas Meyer Cosmetics. For a stock white-label formula in a standard airless pump at 100–300 units, expect a fill cost of $4–$7 per 30 ml unit, plus $1.50–$4 per unit for packaging, and $0.50–$1 per unit for labeling — so a landed total of roughly $6–$12 per unit before freight. At 500+ units that same formula typically drops to $3.50–$5 per unit for fill, bringing the landed total closer to $5.50–$9. Custom formulations carry additional front-loaded costs: a formula development fee of $1,500–$6,000 (one-time, not per unit), stability testing at $800–$2,500 per study, and micro/challenge testing at $400–$900. These are fixed costs you spread across your run — on a 500-unit first batch a $3,000 development fee adds $6 per unit to your effective cost; on a 2,000-unit run it adds only $1.50 per unit. Peptide concentration is the single biggest variable inside the formula cost itself. A 2% Matrixyl 3000 inclusion might add $0.30–$0.60 per unit; a 10% inclusion could add $1.50–$3 per unit. Exosome complexes or rare biofermentation peptides can add $5 or more per unit on their own. Packaging tier is the second largest variable. A generic airless pump from a manufacturer's stock costs $0.80–$1.50 per unit. A custom-decorated glass jar with a metallic lid and hot-stamp logo can reach $3.50–$6 per unit at low quantities. Many indie founders underestimate packaging and end up with a COGS that makes the retail price uncompetitive. The practical advice: build a cost model that assumes a retail price of 5–8x your total landed COGS (including development amortization). If your peptide night cream needs to retail at $45 to be positioned correctly in prestige skincare, your all-in landed cost should ideally stay under $8–$9 per unit. If it cannot, revisit the peptide concentration, packaging tier, or batch size before committing. AJ Cosmo Labs manufacturers list their MOQ and cost tiers so you can filter and compare before ever making contact.

The total timeline from initial product brief to finished goods in your hands runs 8–20 weeks depending on whether you are working with a stock formula or a custom formulation, and whether you are selling into a regulated market that requires additional safety documentation. For a stock peptide night cream formula — one the manufacturer already has on the shelf, tested, and documented — the timeline compresses significantly. Weeks 1–2 cover brief alignment and sample dispatch. Weeks 3–5 cover your sample evaluation and any minor adjustments (fragrance swap, texture tweak). Weeks 6–9 cover bulk production, fill and finish, and shipment. Total: 8–10 weeks is realistic if you make decisions quickly. For a custom formulation the timeline expands. Formula development and first bench sample typically takes 3–6 weeks from brief sign-off. Sample review and revision rounds add another 2–4 weeks — plan for two to three rounds rather than one. Stability testing is the unavoidable bottleneck: even accelerated stability studies (40 °C / 75% RH) take a minimum of 4 weeks for interim data and 12 weeks for full 3-month data. Many manufacturers will release product for sale on interim 4-week data for domestic US sales while the full study completes, but the EU Cosmetic Products Regulation requires a full Cosmetic Product Safety Report (CPSR) before market entry, which needs completed stability data. Bulk production, fill, and finish typically takes 2–4 weeks after formula lock. Add 1–3 weeks for international shipping if manufacturing overseas. Total for a full custom run: 16–20 weeks is the realistic planning figure. The most common mistake founders make is starting the packaging and label design process after the formula is finalized. These should run in parallel. By the time your bench sample is approved, your Dieline, label artwork, and packaging order should already be in production — otherwise packaging delays push your launch date back by 6–10 weeks, which is entirely avoidable. Regulatory documentation — FDA facility registration, Safety Data Sheet, EU CPSR, AICS notification for Australia — should be scoped and assigned in the first two weeks of the project. Founders who treat this as a post-production task frequently miss their target retail window. Download AJ Cosmo Labs on the App Store to post your brief and get manufacturer timelines upfront, before you commit.

A well-formulated peptide anti-aging night cream uses a purposeful blend of signal peptides, carrier peptides, and enzyme-inhibiting peptides rather than a single hero active. The most clinically documented and commercially available options, and their typical use concentrations, are as follows. Matrixyl 3000 (palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7, supplied by Sederma) is the benchmark signal peptide combination. It signals fibroblasts to produce collagen types I and III and reduces inflammatory cytokines. Effective use range is 3–8% of the total formula weight. It is water-soluble, stable in emulsions at pH 5–7, and well-tolerated — which makes it the default starting point for most anti-aging night cream formulas. Argireline (acetyl hexapeptide-3, supplied by Lipotec) is a neurotransmitter-release inhibitor. It is most effective in the periocular and forehead areas and is widely included in night creams targeting expression lines. Use concentration: 5–10%. It is heat-sensitive — do not add above 40 °C during manufacturing. Leuphasyl (pentapeptide-18, from Lipotec) works synergistically with Argireline. Combined at a 1:2 ratio of Leuphasyl to Argireline it is shown in manufacturer studies to enhance the expression-line benefit compared to either ingredient alone. Use at 4–5%. Matrixyl Morphomics (palmitoyl tripeptide-38, Sederma) targets the dermal-epidermal junction and is one of the more expensive peptide actives. It is well-suited to night formulas targeting structural aging rather than just surface wrinkles. Use at 2–4%. Cost is notably higher than Matrixyl 3000 and will affect unit economics meaningfully. GHK-Cu (copper tripeptide-1) is a carrier peptide with wound-healing and collagen-stimulating data. It is notoriously tricky to formulate — it oxidizes in the presence of certain preservatives and is incompatible with high concentrations of vitamin C. pH must be maintained at 5.5–6.5. Effective use range: 0.5–2%. Supportive actives that compound peptide performance in a night cream include retinol or bakuchiol (cell turnover), niacinamide (barrier support and tone), ceramides (transepidermal water loss reduction), and hyaluronic acid (hydration reservoir). A cosmetic chemist will ensure these do not destabilize the peptide actives — for example, low-pH vitamin C and copper peptides must not coexist in the same formula. When evaluating a manufacturer's peptide night cream stock formula, always ask for the INCI list with percentage ranges and the trade name of the peptide ingredient so you can verify the supplier. Generic labels like 'peptide complex' without a CAS number or supplier disclosure are insufficient for premium brand claims. AJ Cosmo Labs connects you to cosmetic chemists who can review a formula brief or evaluate a manufacturer's existing peptide stock formula before you commit.

Finding a low-MOQ contract manufacturer for a peptide night cream requires vetting across four dimensions: technical capability, quality systems, business fit, and communication reliability. Most founders underweight the last two and pay for it in missed timelines and lost deposits. The first channel most founders try is trade directories — Thomasnet, Kompass, and the contract manufacturer listings on Cosmetic Business or Happi. These directories are broad but largely unvetted. Anyone can list; there is no audit of GMP status, peptide sourcing, or financial stability. You can find leads here, but you must do all the qualification work yourself. Trade shows are the gold standard for in-person manufacturer evaluation — Cosmoprof North America (Las Vegas, July), in-cosmetics (rotating European city, April), and Beauty World Middle East are the three most relevant. Meeting a manufacturer's technical and sales team in person and getting a real-time product demonstration is valuable, but this approach requires travel budget and months of planning that early-stage founders often lack. Referrals from other indie brand founders are highly effective. Skincare founder communities on social platforms and in private Discord or Slack groups frequently share manufacturer recommendations and warnings. The limitation is that referrals are biased toward whoever the referrer used — you are not getting a comparative view of the market. The most efficient modern approach for low-MOQ cosmetic brands is a purpose-built marketplace that pre-vets manufacturers for GMP, MOQ range, and category specialization before listing them. The AJ Cosmo Labs app does exactly this — you post a product brief once, including your target MOQ and any specific requirements like peptide actives or clean-beauty positioning, and qualified manufacturers respond with quotes. All messaging is on-platform and all payments are escrowed so you are protected at every stage. When evaluating any manufacturer shortlist, request and verify: ISO 22716 or equivalent GMP certification, a current client reference who produces runs in your size range, a sample of their existing peptide formula with a full INCI list and CoA for each peptide active, and their micro-testing process. Ask specifically how they handle small-batch scheduling — a large manufacturer who accepts low-MOQ clients may queue your 200-unit run behind large commercial accounts and miss committed timelines. Get the production slot commitment in writing before paying a deposit. Red flags to disqualify immediately: inability to provide a full INCI list, no in-house cosmetic chemist, stability data older than 18 months on stock formulas, and any manufacturer who requests full payment upfront. The AJ Cosmo Labs iOS app structures payments into protected milestones precisely to prevent the deposit-and-disappear scenario that plagues indie brand founders working with unvetted manufacturers.

Peptide anti-aging night creams are regulated as cosmetics in both the United States and European Union — not as drugs — provided the marketing claims remain within cosmetic claim territory (improving the appearance of fine lines rather than treating, curing, or preventing any condition). The regulatory obligations differ meaningfully between the two markets. In the United States, the FDA regulates cosmetics under the Federal Food, Drug, and Cosmetic Act as amended by the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Under MoCRA, effective since late 2023, cosmetic brands must register their facilities with the FDA, list their products with the FDA, maintain safety substantiation records, and comply with Good Manufacturing Practices once the FDA finalizes the GMP rule (expected 2025). There is no pre-market approval requirement — you do not submit your formula for FDA review before selling. However, you are legally required to have safety substantiation on file, which for a peptide night cream means stability data, micro testing results, a safety assessment, and ingredient-level safety data. The INCI ingredient list must appear on the label in descending order of concentration, and no prohibited or restricted cosmetic ingredients may be included. If you make drug-adjacent claims — for example, 'stimulates collagen production' or 'repairs DNA damage' — the FDA may classify the product as an over-the-counter drug and require a different regulatory pathway. Stick to appearance-focused language: 'visibly reduces the look of fine lines', 'skin appears firmer', 'helps skin look more youthful'. In the European Union, cosmetics are regulated under the EU Cosmetics Regulation (EC) No. 1223/2009. Before placing a product on the EU market you must appoint a Responsible Person (RP) within the EU, compile a full Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor, complete a Product Information File (PIF), and register the product on the EU Cosmetics Notification Portal (CPNP). The CPSR requires completed stability data and must be reviewed and signed by a person with a relevant university degree (pharmacy, toxicology, medicine, chemistry, or similar). Annex II of the Regulation lists over 1,300 prohibited substances; Annexes III–VI list restricted and regulated substances with concentration limits. Most standard peptide actives are permissible, but always verify with your cosmetic chemist. For both markets, California's Proposition 65 is a practical concern if you sell into California — it requires a warning label if the product contains any listed chemicals above safe harbor levels. Some fragrance components and preservative ingredients cross this threshold, which is another reason to get a formulation review from a qualified cosmetic chemist before finalizing your formula. Canada (Health Canada, Cosmetic Regulations under the Food and Drugs Act), Australia (AICS, NICNAS), and the UK (UK OPSS post-Brexit) each have their own notification or registration requirements. If you plan to sell into multiple markets simultaneously, scope your regulatory obligations in week one of your development project, not at launch. Manufacturers listed on AJ Cosmo Labs often have experience with multi-market regulatory documentation and can advise on what documentation they provide as part of the manufacturing agreement.

You can absolutely private label an existing peptide night cream formula — and for most first-time founders, it is the strategically correct choice. The tradeoffs between stock (white-label) formulas and custom formulations are real, and the right answer depends on your brand positioning, budget, and timeline. A stock or white-label peptide night cream is a formula that the contract manufacturer has already developed, stability-tested, and in many cases is already producing for other brands. You apply your brand name, label design, and packaging to a finished formula that is ready to go. The advantages are substantial: MOQs as low as 100–200 units, no formula development fee (or a nominal one), lead times of 6–10 weeks rather than 16–20, and zero stability testing cost because the study has already been run. The disadvantage is that the formula is not exclusive — other brands may be selling products built on the same base, which limits your ability to claim a truly differentiated formulation. For stock formulas, the differentiation levers available to you are: packaging design and materials, brand positioning and storytelling, fragrance (many manufacturers will swap the fragrance component within certain limits), and concentration adjustments within a narrower range. Some manufacturers offer 'semi-custom' options where you can add one or two additional actives (a plant extract, an extra peptide fraction) to an existing stock base at a modest fee and a slightly higher MOQ. A fully custom formulation is developed specifically for your brand. It can be exclusive (the manufacturer agrees not to license it to another brand, which should be written explicitly into your contract with an exclusivity period), it allows you to build a genuine IP story around your formula, and it gives you control over every ingredient at specific concentrations. The cost is higher — expect $1,500–$6,000 in development fees, 12–20 weeks of lead time, and an MOQ of 500–2,000 units for the first production run. The practical guidance for indie founders: if you are testing market fit with a first SKU on a limited budget, start with a stock formula. Use the revenue and customer feedback from the first run to fund a custom formulation for the second generation of the product. This is the path most successful indie skincare brands have followed. Whichever route you choose, always request the full INCI list, CoA for each peptide active, stability study data, and micro-testing results — these should be non-negotiable deliverables from any manufacturer, stock or custom. AJ Cosmo Labs manufacturers indicate in their profiles whether they offer stock, semi-custom, or fully custom formulation options, so you can filter by the route that fits your current stage when you post your brief on the iOS app.